Klotz T - Search Results

1

Nitric oxide pathways in human bladder carcinoma. The distribution of nitric oxide synthases, soluble guanylyl cyclase, cyclic guanosine monophosphate, and nitrotyrosine.

Ehsan A, Sommer F, Schmidt A, Klotz T, Koslowski J, Niggemann S, Jacobs G, Engelmann U, Addicks K, Bloch W. Ehsan A, et al. Among authors: klotz t. Cancer. 2002 Dec 1;95(11):2293-301. doi: 10.1002/cncr.10942. Cancer. 2002. PMID: 12436434 Free article.

2

Differential endostatin binding to bladder, prostate and kidney tumour vessels.

Schmidt A, Sommer F, Reiner M, Klotz T, Engelmann U, Addicks K, Bloch W. Schmidt A, et al. Among authors: klotz t. BJU Int. 2005 Jan;95(1):174-9. doi: 10.1111/j.1464-410X.2005.05272.x. BJU Int. 2005. PMID: 15638918

3

Evaluation of tetrahydrobiopterin (BH4) as a potential therapeutic agent to treat erectile dysfunction.

Sommer F, Klotz T, Steinritz D, Bloch W. Sommer F, et al. Among authors: klotz t. Asian J Androl. 2006 Mar;8(2):159-67. doi: 10.1111/j.1745-7262.2006.00122.x. Asian J Androl. 2006. PMID: 16491266 Free article. Clinical Trial.

4

Cycling and penile oxygen pressure: the type of saddle matters.

Schwarzer U, Sommer F, Klotz T, Cremer C, Engelmann U. Schwarzer U, et al. Among authors: klotz t. Eur Urol. 2002 Feb;41(2):139-43. doi: 10.1016/s0302-2838(01)00028-8. Eur Urol. 2002. PMID: 12074400

5

Vessels in benign prostatic hyperplasia contain more binding sites for endostatin than vessels in normal prostate tissue.

Schmidt A, Sommer F, Ozgür E, Klotz T, Engelmann U, Addicks K, Bloch W. Schmidt A, et al. Among authors: klotz t. Eur Urol. 2004 Dec;46(6):765-7. doi: 10.1016/j.eururo.2004.07.027. Eur Urol. 2004. PMID: 15548445

6

Improved spontaneous erectile function in men with mild-to-moderate arteriogenic erectile dysfunction treated with a nightly dose of sildenafil for one year: a randomized trial.

Sommer F, Klotz T, Engelmann U. Sommer F, et al. Among authors: klotz t. Asian J Androl. 2007 Jan;9(1):134-41. doi: 10.1111/j.1745-7262.2007.00233.x. Asian J Androl. 2007. PMID: 17187165 Clinical Trial.

7

Patients responding to phosphodiesterase type 5 inhibitor therapy: what do their sexual partners know?

Klotz T, Mathers M, Klotz R, Sommer F. Klotz T, et al. Among authors: klotz r. J Sex Med. 2007 Jan;4(1):162-165. doi: 10.1111/j.1743-6109.2006.00346.x. Epub 2006 Nov 6. J Sex Med. 2007. PMID: 17087808

8

Long-term treatment of erectile dysfunction with a phosphodiesterase-5 inhibitor and dose optimization based on nocturnal penile tumescence.

Mathers MJ, Klotz T, Brandt AS, Roth S, Sommer F. Mathers MJ, et al. Among authors: klotz t. BJU Int. 2008 May;101(9):1129-34. doi: 10.1111/j.1464-410X.2007.07376.x. Epub 2008 Jan 10. BJU Int. 2008. PMID: 18190629 Clinical Trial.

9

Patients with localised prostate cancer (t1 - t2) show improved overall long-term survival compared to the normal population.

Mathers MJ, Roth S, Klinkhammer-Schalke M, Gerken M, Hofstaedter F, Wilm S, Klotz T. Mathers MJ, et al. Among authors: klotz t. J Cancer. 2011 Feb 8;2:76-80. doi: 10.7150/jca.2.76. J Cancer. 2011. PMID: 21326628 Free PMC article.

10

Merkel cell carcinoma -- a rarity in the urogenital tract.

Schwindl B, Meissner A, Giedl J, Klotz T. Schwindl B, et al. Among authors: klotz t. Onkologie. 2006 Jul;29(7):326-8. doi: 10.1159/000093661. Epub 2006 Jul 3. Onkologie. 2006. PMID: 16874017

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters